We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Targeting transitioning lung monocytes/macrophages as treatment strategies in lung disease related to environmental exposures

    Background

    Environmental/occupational exposures cause significant lung diseases. Agricultural organic dust extracts (ODE) and bacterial component...

    Aaron D. Schwab, Todd A. Wyatt, ... Jill A. Poole in Respiratory Research
    Article Open access 09 April 2024
  2. Bone-metastatic lung adenocarcinoma cells bearing CD74-ROS1 fusion interact with macrophages to promote their dissemination

    Approximately 40% of patients with lung adenocarcinoma (LUAD) often develop bone metastases during the course of their disease. However, scarcely any...

    Zhao Wang, Zhe Lei, ... Hong-Tao Zhang in Oncogene
    Article 27 May 2024
  3. PD-L2 overexpression on tumor-associated macrophages is one of the predictors for better prognosis in lung adenocarcinoma

    Immunotherapies that target programmed cell death protein 1 (PD-1) signals are standard therapies for advanced-stage lung cancer, and the expression...

    Eri Matsubara, Yusuke Shinchi, ... Makoto Suzuki in Medical Molecular Morphology
    Article 04 July 2023
  4. Clinical Significance of SIRPĪ± Expression on Tumor-Associated Macrophages in Patients with Lung Squamous Cell Carcinoma

    Background

    Signal-regulatory protein alpha (SIRPĪ±) is an immune checkpoint molecule expressed on macrophages that functions to inhibit phagocytosis by...

    Taichi Nagano, Kazuki Takada, ... Tomoharu Yoshizumi in Annals of Surgical Oncology
    Article 29 June 2024
  5. Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease

    Background

    Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by vasculopathy and progressive fibrosis of skin and...

    Stefano Soldano, Vanessa Smith, ... Maurizio Cutolo in Arthritis Research & Therapy
    Article Open access 20 March 2024
  6. Nesfatin-1 alleviated lipopolysaccharide-induced acute lung injury through regulating inflammatory response associated with macrophages modulation

    Acute lung injury (ALI) is a continuum of lung changes associated with uncontrolled excessive lung inflammation. However, the pathogenesis of ALI is...

    Hongbing Cheng, Yanfang Zhu, ... Yalan Wang in Journal of Cardiothoracic Surgery
    Article Open access 26 August 2022
  7. Evolving polarisation of infiltrating and alveolar macrophages in the lung during metastatic progression of melanoma suggests CCR1 as a therapeutic target

    Metastatic tumour progression is facilitated by tumour associated macrophages (TAMs) that enforce pro-tumour mechanisms and suppress immunity. In...

    Thomas T. Tapmeier, Jake H. Howell, ... Annamaria Gal in Oncogene
    Article Open access 14 October 2022
  8. Prognostic impact of soluble PD-L1 derived from tumor-associated macrophages in non-small-cell lung cancer

    Programmed cell death-ligand 1 (PD-L1) on tumor cells can be degraded to soluble form (sPD-L1) and enter circulation, however, the clinical...

    Koji Teramoto, Tomoyuki Igarashi, ... Yataro Daigo in Cancer Immunology, Immunotherapy
    Article Open access 30 August 2023
  9. The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma

    Programmed cell death-1 (PD-1) and PD-1 ligand 1 (PD-L1) are target molecules for immunotherapy in non-small cell lung cancer. PD-L1 is expressed not...

    Yusuke Shinchi, Shiho Ishizuka, ... Makoto Suzuki in Cancer Immunology, Immunotherapy
    Article 29 March 2022
  10. Prognostic impact of the number of peri-tumoral alveolar macrophages in patients with stage I lung adenocarcinoma

    Purpose

    Intratumoral macrophages are reportedly involved in tumor progression in non-small cell lung cancer; however, little is known about the...

    Osamu Noritake, Keiju Aokage, ... Genichiro Ishii in Journal of Cancer Research and Clinical Oncology
    Article 02 July 2022
  11. Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma

    Introduction

    This study aimed to clarify the correlation between the number of AMs and prognosis and to examine the gene expression of AMs in lung...

    Yu Tanaka, Tokiko Nakai, ... Genichiro Ishii in Cancer Immunology, Immunotherapy
    Article 02 March 2023
  12. PPARĪ³ attenuates cellular senescence of alveolar macrophages in asthma-COPD overlap

    Background

    Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) represents a complex condition characterized by shared clinical and...

    Rongjun Wan, Prakhyath Srikaram, ... Peisong Gao in Respiratory Research
    Article Open access 20 April 2024
  13. CD36/Lyn kinase interactions within macrophages promotes pulmonary fibrosis in response to oxidized phospholipid

    Recent data from human studies and animal models have established roles for type II alveolar epithelial cell (AEC2) injury/apoptosis and...

    Doyun Kwak, Patrick B. Bradley, ... Kevin K. Kim in Respiratory Research
    Article Open access 14 December 2023
  14. The roles of tissue resident macrophages in health and cancer

    As integral components of the immune microenvironment, tissue resident macrophages (TRMs) represent a self-renewing and long-lived cell population...

    Minmin Cao, Zihao Wang, ... Yue Zhao in Experimental Hematology & Oncology
    Article Open access 16 January 2024
  15. A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis

    Tumor-associated macrophages (TAMs) are abundant in tumors and interact with tumor cells, leading to the formation of an immunosuppressive...

    Qingyang Lei, Shanshan Zhen, ... Yi Zhang in Cancer Immunology, Immunotherapy
    Article Open access 20 April 2024
  16. Effects of electroacupuncture pretreatment on M1 polarization of alveolar macrophages in rats with acute lung injury

    Objective

    To observe the effects of electroacupuncture (EA) pretreatment on M1 polarization of alveolar macrophages (AMs) in rats with acute lung...

    Yi Zhang, **gchao Su, ... Zibing Liu in Journal of Acupuncture and Tuina Science
    Article 25 February 2022
  17. Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension

    Inflammation and immune processes underlie pulmonary hypertension progression. Two main different activated phenotypes of macrophages, classically...

    Yifan Zuo, Boyang Li, ... Qing Geng in Respiratory Research
    Article Open access 30 March 2024
  18. Macrophages in immunoregulation and therapeutics

    Macrophages exist in various tissues, several body cavities, and around mucosal surfaces and are a vital part of the innate immune system for host...

    Shanze Chen, Abdullah F.U.H. Saeed, ... Yanhong Duo in Signal Transduction and Targeted Therapy
    Article Open access 22 May 2023
  19. Immunomodulatory macrophages and Treg in pulmonary hypertension

    Pulmonary hypertension (PH) is a disease that affects the right ventricle and venous circulation. The need for improvement in the discovery of novel...

    Ayobami Matthew Olajuyin, Adefunke Kafayat Olajuyin, ... Qinghua Hu in Comparative Clinical Pathology
    Article 24 November 2023
  20. Alveolar macrophage-derived gVPLA2 promotes ventilator-induced lung injury via the cPLA2/PGE2 pathway

    Background

    Ventilator-induced lung injury (VILI) is a clinical complication of mechanical ventilation observed in patients with acute respiratory...

    Hanghang Han, Qiuwen **e, ... Xueke Du in BMC Pulmonary Medicine
    Article Open access 06 December 2023
Did you find what you were looking for? Share feedback.